Jaguar Animal Health, Inc. (JAGX) vs Lisata Therapeutics, Inc. (LSTA)

Jaguar Animal Health, Inc. and Lisata Therapeutics, Inc. are both Biotechnology companies. Jaguar Animal Health, Inc. and Lisata Therapeutics, Inc. are of similar size ($9.6M and $8.9M). Lisata Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; Jaguar Animal Health, Inc. trades at 0.0×. Jaguar Animal Health, Inc. grew revenue faster over the last twelve months: 135.5% against −24.7%. Lisata Therapeutics, Inc. has the higher net margin (0.00% vs −188.5%) and the higher return on invested capital (0.00% vs −28,393.6%). Across the 18 metrics below, Jaguar Animal Health, Inc. leads on 9 and Lisata Therapeutics, Inc. on 9.

Valuation

Metric JAGX LSTA Biotechnology median
P/E 0.00 n/m 8.50
P/S 0.01 0.62 9.71
P/B 0.04 1.17 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.13 n/m 0.64
EV/Sales (0.11) 0.14 9.21
Earnings yield 51,230.90% (159.22%) (33.15%)
Free cash flow yield (3,867.38%) (131.69%) (25.50%)

Profitability

Metric JAGX LSTA Biotechnology median
Gross margin 82.31% 0.49% 65.16%
Operating margin (93.10%) 0.00% 0.00%
Net margin (188.46%) 0.00% 0.00%
Free cash flow margin (24.03%) 0.00% 0.00%
Return on equity (1,125.38%) (101.66%) (56.36%)
Return on assets (127.14%) (80.81%) (48.04%)
Return on invested capital (28,393.64%) 0.00% 0.00%

Growth

Metric JAGX LSTA Biotechnology median
Revenue growth (TTM) 135.52% (24.67%) 6.02%
EPS growth (last fiscal year) 82.42% 20.42% 30.26%
Revenue growth, 5-year CAGR 4.17% (20.28%) 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric JAGX LSTA Biotechnology median
Debt to equity 0.35 0.00 0.00
Current ratio 0.69 3.69 4.72
Net debt to EBITDA (0.17) 0.88 0.96

Dividend

Metric JAGX LSTA Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric JAGX LSTA Biotechnology median
Market cap 8.93m 9.64m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack